Dr. Christopher Lipinski was Adjunct Senior Research Fellow at the Pfizer Global R&D Groton CT Laboratories following his retirement in June 2002 and is now a Scientific Advisor to Melior Discovery, a drug repurposing startup. He is a member of the American Chemical Society (ACS), AAPS, Society of Biomolecular Sciences (SBS), and EUFEPS. A consultant on drug-like properties he serves on numerous scientific advisory and journal editorial boards. He is the author of the "rule of five" a widely used filter to select for acceptable drug oral absorption. In 2006, he received an honorary law degree from the University of Dundee and is the 2006 Society for Biomolecular Sciences Achievement Award winner. In 2005, he was the American Chemical Society winner of the E. B. Hershberg Award for Important Discoveries in Medicinally Active Substances, and in 2004 the winner of the Division of Medicinal Chemistry Award of the ACS Division of Medicinal Chemistry. Since 1984, he has been an adjunct faculty member at Connecticut College in New London CT, and has over 225 publications and invited presentations and 17 issued US patents.
This person is not in the org chart